Updates to IBS Impact.com for January-February 2016

February 4, 2016

IBS Impact has recently completed its latest update to many pages of the main website.

There have also been new details and resources added in the latest news column on the left of the home page,  IBS page, advocacy page, research pageIBS studies page, resources page, family and friends page and links page.  The most extensive modifications  for this round involve the IBS, advocacy, research, and family and friends pages.

Readers interested in the most recent news, events, clinical trial and advocacy opportunities, and articles between main site updates, may follow this blog or our Facebook or Twitter feeds (links found on the lower right sidebar of this blog). Regardless of one’s interest in IBS, whether personal or professional, most users should find useful and interesting material and links. The current site reflects resources in six countries which are among the top sources of hits to the site and this blog.

Because of the redesign and transfer of the site to new hosting in the fall of 2015, some links embedded in older posts on this blog or search engine results relating to IBS Impact.com may result in error messages, but you should still reach the site itself. If so, please use the navigation links at the top of the site to reach the desired subpage.  No information that is still currently useful has been removed from the site, although in some cases, the location has changed. Only outdated details and occasional defunct links for which there is no replacement available at this time have been deleted.

Please feel free to check out the site here. Our goals with the website, blog and social media are to provide a varied range of current, scientifically accurate, reputable information and resources to people with IBS and their families and friends, and to encourage informed choices, proactive self-advocacy and public awareness of IBS, and the unmet medical or social needs many of us face as a result of IBS.

IBS Impact, as an entity, is not directly affiliated with any other organization, site or research sponsor and receives no funding for the information we post on the main website, this blog or our Twitter and Facebook pages. We do welcome constructive collaboration and value the many individuals, websites, organizations and clinical and research entities who continue to support, encourage and amplify our efforts in various ways to benefit the cause of IBS awareness and advocacy worldwide.

Comments, suggestions, corrections of outdated links, article submissions, and clinical trials or surveys by researchers affiliated with academic, medical, or pharmaceutical entities or reputable organizations representing IBS or commonly overlapping conditions in any country are all welcome and will be thoughtfully considered.  A new contact form can be found on the home page of the main site, or comments can be left on this blog.  Thank you to all of our readers and social media followers for your interest and participation.


Online Survey: Adults with IBS and Parents/Caregivers of Children with IBS in Canada, January 2016

January 26, 2016

The Gastrointestinal (GI) Society, also known as the Canadian Society of Intestinal Research, is inviting people residing throughout Canada who have irritable bowel syndrome or are parents or caregivers of children with irritable bowel syndrome to take part in an anonymous online survey. This survey will ask about day to day experiences, opinions and effects of IBS and will be used by the GI Society to shape the organization’s programs and community awareness and advocacy among health care providers and policy makers and the general public.

The survey will be open and available on the GI Society website until April 30, 2016 and can be accessed at the following link.

http://www.badgut.org/ibs-survey/

If you voluntarily choose to provide the GI Society with contact information at the end of the survey, you will be entered into a random drawing for an iPad mini. The drawing will take place on May 2, 2016.

Please address any questions about this survey directly to the GI Society.

We welcome researchers affiliated with academic, medical or pharmaceutical entities, or reputable organizations representing IBS or related or commonly overlapping conditions, to contact us directly with additional studies or surveys they wish to be considered for posting. A contact form is available on the main IBS Impact website.

IBS Impact makes these announcements available for general information, and encourages its members and site visitors to make their own individual, informed choices about their potential participation.  IBS Impact, as an entity, is not directly affiliated with any research sponsor or organization and receives no funding from any source for studies, surveys or links we feature on this blog, the main site or social media.


IBS Impact’s Top 25 (or 46!) Countries and Top 10 (or 11!) Posts of 2015

January 1, 2016

For this first week of the New Year, IBS Impact is once again participating in the common December-January blogger tradition of highlighting popular posts and interesting blog statistics from the year just past.

This blog reached readers in 86 countries and territories during 2015, and 133 in the four years that WordPress has made country statistics available to individual blog owners. While, predictably, most of the nations in the top 10 are ones where English is an official or major secondary language, our total blog hits span every continent, underscoring that IBS is a global problem, not the common, inaccurate stereotype of it as a nuisance disorder caused by overindulgent North American diets and lifestyles. A list of the top 25 better reflects the diversity of countries of origin represented. This year, because of several multinational ties in the statistics of anywhere from two to seven countries, the top 25 places are actually occupied by 46 countries. It is hoped that the vast majority are legitimate visits, even from those who might not have been searching specifically for information about IBS, and not simply potential spammers. In order, the countries are:

1. United States

2. United Kingdom

3. Canada

4. Australia

5. India

6. New Zealand

7. Ireland

8. Russia

9.  (tie) Germany and Sweden

10. Japan

11. Netherlands

12. Malaysia

13. Italy

14. (tie) Norway, Romania, Mexico, and Spain

15. (tie) Philippines and South Africa

16. (tie) Saudi Arabia and Portugal

17. Bangladesh

18. Hungary

19. (tie) Thailand, Denmark and Switzerland

20. (tie) Poland, South Korea, France, Qatar, and Greece

21. Belgium

22. Argentina

23. (tie)  United Arab Emirates, Turkey, Pakistan, Israel, Indonesia, Brazil, and Austria

24. (tie) Singapore, Bulgaria and China

25. (tie) Puerto Rico, which is a U.S. commonwealth, and Finland.

Below are the top 10 individual posts that received the most hits during 2015, with one tie resulting in a list of 11. The majority of them were first published in 2011, 2012 or 2013 or 2014. However, they continue to attract attention because they address topics that are of ongoing concern to people with IBS. Perhaps longtime readers can refresh their memories and newer readers will discover something interesting and useful. In order, the posts are:

1. Functional Gastrointestinal Disorders/IBS Considered Presumptive Service-Connected Disabilities for U.S. Gulf War Veterans,  August 12, 2011

2. The Americans with Disabilities Act (ADA) and Irritable Bowel Syndrome (IBS), July 30, 2012

3. Irritable Bowel Syndrome (IBS) and a Debate on “Can’t Wait” Cards,  November 25, 2012 Please note that the blog originally linked in the above post as a basis for discussion no longer exists on WordPress.com. However, the ideas raised and the invitation by IBS Impact for readers and the IBS community to continue to discuss related concerns are still valid.

4. The American College of Gastroenterology Issues 2014 Evidence-Based Review on the Management of Irritable Bowel Syndrome (IBS), August 10, 2014

5. Restroom Access Act (Ally’s Law) Updates in Maryland and Maine, May 10, 2013

6. Massachusetts Enacts Restroom Access Act,  August 20, 2012

7. Public Restroom Access and Irritable Bowel Syndrome (IBS), February 21, 2012

8. Education Laws and Resources for Students with Irritable Bowel Syndrome (IBS), August 27, 2013

9. (tie)  15 Common Misconceptions That Shouldn’t Exist about Irritable Bowel Syndrome (IBS), November 8, 2013

and NICE Guidelines in the United Kingdom for Adult Irritable Bowel Syndrome Updated for 2015, March 6, 2015

10. New Rome IV Diagnostic Criteria for Irritable Bowel Syndrome (IBS) Will Include Individualized Clinical Profiles, October 11, 2015

This blog was begun in July 2011, a few months after the launch of the main IBS Impact website, and a bit over a year after the inception of IBS Impact itself. It is intended as a supplement to the many resources on our main site, one that can be updated relatively quickly with time-sensitive news, advocacy and clinical trial opportunities, as well as providing well-researched, scientifically reputable information on IBS and commentary on broader issues affecting the IBS community that may not be widely discussed on other sites. It is meant to be useful to a broad readership: people with IBS and related conditions, both those who may have lived with IBS for some time and those with recent onset or who are new to IBS sites online, family members and friends, health care and human service professionals who may interact with us, and the general public. We are pleased that it continues to fulfill this role.

IBS Impact wishes everyone a happy, healthy, prosperous and productive New Year and looks forward in 2016 to advances in awareness, advocacy, research, treatment and community support systems that benefit the worldwide IBS community.


Representatives Loebsack of Iowa and Rothfus of Pennsylvania Co-Sponsor HR 2311 for Functional Gastrointestinal and Motility Disorders

December 20, 2015

According to IFFGD/the Digestive Health Alliance and the official Congressional legislative database Congress.gov, Representatives Dave Loebsack (D-IA-2) and Keith Rothfus (R-PA-12) have recently signed on as co-sponsors to the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2015.

Representative Loebsack is serving his fifth term in the House of Representatives. His district, the 2nd Congressional District of Iowa encompasses most of the southeastern region of the state including  the cities of Davenport, Iowa City, Clinton  and Ottumwa, among others. According to his official House website, Representative Loebsack is currently a member of the House Energy and Commerce Committee, which includes the Subcommittee on Health. He has immediate family members currently serving in the military, previously served on the House Committee on Armed Services, and also has a strong record of supporting veterans’ issues. As previously discussed on this blog on August 12, 2011 and August 25, 2011, military service members and veterans are at disproportionately high risk for functional gastrointestinal disorders like IBS, which are already very common in the general population.

Representative Rothfus is serving his second term in the House of Representatives. His district, the 12th Congressional District of Pennsylvania encompasses most of the southwestern region of the state including all of Beaver County, and parts of Allegheny, Cambria, Lawrence, Somerset and Westmoreland Counties. According to his official House website, Representative Rothfus has a record of supporting various veterans’ issues and is currently a member of several caucuses related to other specific health conditions.

If you are a constituent of Representative Loebsack or Representative Rothfus, please take a few minutes to write or call him with your thanks for his support of the functional gastrointestinal and motility disorders community.

In officially supporting HR 2311, Representatives Loebsack and Rothfus join Representative F. James Sensenbrenner, Jr. (R-WI-5) , who is the initial sponsor,  Representative Andre Carson (D-IN-7), Representative Zoe Lofgren (D-CA-19) and Representative Gwen Moore (D-WI-4), and Representative David Young (R-IA-3) If you are a constituent of any of these Representatives, please thank them as well.

According to the information on Congress.gov, it appears that the bill is currently under consideration in the Subcommittee on Health. Click on the link above if you would like to see a list of its members.

U. S. citizens, if your Member of Congress is not yet a co-sponsor of HR 2311, please see the previous post from May 18, 2015 for links to the bill and more details on how to do so.  Often, it takes multiple attempts to elicit any interest from legislators, so if you do not receive a reply, do not hesitate to try again or to switch contact methods until you attract attention. Keep in mind that your Representative may be different from before because of the 2014 elections, district boundaries that may have been re-drawn, or if you have moved.

Your personal experiences as a person with IBS and/or other functional GI/motility disorders, or as a concerned family member, friend or colleague, are most effective in communicating to legislators and their staff that there are real human beings behind the statistics. However, even general expressions of support are helpful.

HR 2311 is bipartisan legislation (supported by members of both parties) and according to IFFGD discussions with IBS Impact,  is “revenue-neutral,” meaning that there will be no additional taxes or spending added to the current federal deficit if it is enacted. Discretionary funds are available at the National Institutes of Health to be allocated if Congress directs NIH, through this Act, that functional gastrointestinal and motility disorders are a priority. Congress will only do so if we, as a community, are able to show them the importance of the research, education and FDA coordination provided for in HR 2311.

NIH grants funding to researchers throughout the world, not just in the U.S., so in the long run, enactment of this Act may also benefit readers with IBS in other countries. Medical research also sometimes involves multinational teams of scientists, and in any case, study results are usually published globally, adding to the cumulative knowledge worldwide.

It is IBS Impact’s understanding that HR 2311 will not require a debate or vote on the floor of the House of Representatives, and will pass as soon as it reaches 218 sponsor/cosponsors, or a simple majority of the House. In order for this milestone to be accomplished during the current Congress, the 114th,  the necessary number of sponsor/cosponsors must be reached by December 2016. Every two years, the Congressional membership will be different as a result of elections. Thus, if HR 2311 has not passed by that time,  a similar bill will have to be reintroduced and the FGIMD community will have to start the process of gathering co-sponsors anew. This is what occurred with HR 2239 in 2012 and HR 842 in 2014. While it is quite common for legislation of various sorts to take several Congresses to pass, our continuing advocacy now can increase awareness, build momentum and perhaps accelerate passage. It is in our hands.

Check back on this blog or join IBS Impact’s Facebook page or Twitter feed for further updates on HR 2311 as they occur. Links to the social media sites can be found on the right sidebar of the blog.


Book Review: IBS: 365 Tips for Living Well

December 13, 2015

Recently, IBS Impact had the opportunity to read one of the latest books on IBS written for affected people and their family members, IBS: 365 Tips for Living Well by Barbara B. Bolen, PhD (Demos Health: 2016).

Dr. Bolen is a psychologist and health coach in private practice in the Long Island region of New York, and a health writer with particular interest and experience in IBS and other GI conditions. For many years, she has been the IBS Guide for About.com. She is also the author of Breaking the Bonds of Irritable Bowel Syndrome: A Psychological Approach to Regaining Control of Your Life  (New Harbinger Publications: 2000) based on cognitive behavioral therapy techniques shown to be effective for many people with IBS. She is co-author, with Jeffrey D. Roberts, of IBS Chat: Real Life Stories and Solutions (iUniverse: 2007), and coauthor, with Kathleen Bradley, CPC, of The Everything Guide to the Low-FODMAP Diet: A Healthy Plan for Managing IBS and Other Digestive  (Adams Media: 2014). The latter book was reviewed on this blog on November 17, 2014.

IBS: 365 Tips for Living Well is 155 pages long, including all addenda and the index, in the print edition.  It also appears to be available as a Kindle e-book. Similar to Dr. Bolen’s About.com blog, it is written in a scientifically accurate but non-technical language that is easily accessible to most readers who may not have a scientific background. All material is organized into 13 short chapters with a clear table of contents and index. The 365 tips are brief, ranging from a few sentences to a single long paragraph. They are numbered sequentially with the numbers in shaded boxes that catch the eye. Each tip has its own heading with the main point. All headings for tips and chapters are in larger, bolder font for easy readability. Dr Bolen states in her introduction that the format was intentionally designed not to overwhelm readers with information so that individuals can read whatever parts are of interest to them at a given time at their own pace. This should be particularly helpful to readers with busy lives, especially those who are relatively new to information about IBS.

The first chapter focuses on what IBS is, what it is not, and few other conditions that may account for symptoms or coexist with IBS. The second chapter addresses building an effective relationship with one’s doctor, a factor that expert IBS professionals have identified as a strong influence in positive, long-term outcomes for people with IBS. The third and fourth chapters’ tips provide a brief overview of diagnosis, available medications and non-medication options including psychological treatments for IBS. The fifth, sixth and seventh chapters cover various aspects of eating with IBS to minimize common symptoms, from lifestyle changes to diets. The eighth chapter is about handling various aspects of certain symptoms, including possible accidents.

The ninth and tenth chapters are a wealth of tips related to daily life, including work, school, legal protections in the U.S., daily getting around in public as well as more distant travel,  disclosure (or not) of one’s IBS to others, social outings, restaurants, dating and sex life. The eleventh chapter is devoted to family life: the person with IBS and his/her relationship with his or her spouse or partner, parenting when the parent has IBS, and parenting when the child has IBS. Curiously, there are no tips in this section directed at the spouse or partner or other relatives of adults with IBS, but this is a minor omission Dr. Bolen has addressed in her other work in the past.

The twelfth chapter focuses on stress management techniques, and interestingly, includes specific mention of finances, which are a common stressor for many people in general and may become complicated by unpredictable chronic conditions like IBS with possibly increased expenses or potential difficulties maintaining employment. The thirteenth chapter has general, self care tips for healthy living not specific to IBS, such as good sleep habits. The back of the book also includes two pages of “Essential Resources” which are books, organizations and websites that Dr. Bolen suggests for further information. IBS Impact thanks her for including our main website on her list, which was an unsolicited surprise. A bibliography of her scientific sources, acknowledgements and the index round out the book. A few of the tips that appear in different chapters appear to be similar repeats, but again, this is a minor issue.

Overall, the information in IBS: 365 Tips for Living Well appears to be scientifically accurate, balanced and up-to-date as of its publication date of 2016. The advice is generally consistent with the multidisciplinary, biopsychosocial approach advocated by functional GI experts, although Dr. Bolen is slightly more open to controversial theories, such as small intestine bacterial overgrowth (SIBO) and alternative diets than some professionals.

Unsurprisingly, given her background as a psychologist and relative of an individual with IBS, the most compelling parts of the book address how to deal with the wide-ranging emotional and practical daily challenges of an unpredictable chronic condition for which resources in most local communities are few and far between. Although there are many published books on various aspects of IBS written for affected people, most give relatively little attention to the fine details of how people are going to live long-term with IBS once we have run the gamut of diagnosis and currently available interventions. Dr. Bolen’s advice on this complex subject is consistently focused, easily understandable and down to earth. She demonstrates empathy for everyone involved: people with IBS, family members and her fellow professionals, balanced with realism. (“Tip 45: Keep Your Expectations Reasonable.”) There are no extreme promises of quick fix cures to be found here, but plenty of reassurance, guidance and hope. (“Tip 306: Keep It in the Moment.”)

Very devoted readers of Dr. Bolen’s blog and books will find much of this advice already familiar, but pleasantly so. For those relatively new to IBS, this is an excellent, non-intimidating overview of many topics to begin one’s education on IBS.  IBS Impact encourages readers and their families to continue to read and learn widely from reputable, scientifically accurate sources, such as the ones listed in the “Additional Resources” section of the book, Dr. Bolen’s About.com blog, and the many IBS-related links on this blog, the various pages of IBS Impact’s main website, and IBS Impact’s social media. Those who have already lived with IBS for many months, years or decades can still find individual chapters or tips of information they may not have encountered before that may be helpful in managing their lives or in educating those around them. This is a very solid addition to Dr. Bolen’s work and to the reputable resources available to the IBS community.

The copy of the book used for this review was purchased from a major retailer and Dr. Bolen was not aware in advance that this post would be written. IBS Impact receives no funding for this review or for any sales of the book. The observations and phrasing expressed here are original, independent, and not dictated in any way by the book’s author or any publicist. As with all of the information on this blog, our main website and social media, it is provided in the interest of scientifically accurate public awareness and advocacy, and assisting blog readers dealing with IBS to make informed choices for themselves or their families.


Representative David Young of Iowa Co-Sponsors HR 2311 for Functional Gastrointestinal and Motility Disorders

December 2, 2015

According to IFFGD/the Digestive Health Alliance and the official Congressional legislative database Congress.gov, Representative David Young (R-IA-3) has recently signed on as a co-sponsor to the Functional Gastrointestinal and Motility Disorders Research Enhancement Act of 2015.

Representative Young is serving his first term in the House of Representatives. His district, the 3rd Congressional District of Iowa encompasses all or part of 16 counties:  Adair, Adams, Cass, Dallas, Fremont, Guthrie, Madison, Mills, Montgomery, Page, Polk, Pottawattamie, Ringgold, Taylor, Union and Warren. This includes the cities of Des Moines, Creston and Council Bluffs, among others. According to his official House website, Representative Young is a member of the House Committee on Appropriations, and also has a strong record of supporting veterans’ issues. As previously discussed on this blog on August 12, 2011 and August 25, 2011, military service members and veterans are at disproportionately high risk for functional gastrointestinal disorders like IBS, which are already very common in the general population

If you are a constituent of Representative Young, please take a few minutes to write or call him with your thanks for his support of the functional gastrointestinal and motility disorders community.

In officially supporting HR 2311, Representative Young joins Representative F. James Sensenbrenner, Jr. (R-WI-5) , who is the initial sponsor,  Representative Andre Carson (D-IN-7), Representative Zoe Lofgren (D-CA-19) and Representative Gwen Moore (D-WI-4). If you are a constituent of any of these Representatives, please thank them as well.

According to the information on Congress.gov, it appears that the bill is currently under consideration in the Subcommittee on Health. Click on the link above if you would like to see a list of its members.

U. S. citizens, if your Member of Congress is not yet a co-sponsor of HR 2311, please see the previous post from May 18, 2015 for links to the bill and more details on how to do so.  Often, it takes multiple attempts to elicit any interest from legislators, so if you do not receive a reply, do not hesitate to try again or to switch contact methods until you attract attention. Keep in mind that your Representative may be different from before because of the 2014 elections, district boundaries that may have been re-drawn, or if you have moved.

Your personal experiences as a person with IBS and/or other functional GI/motility disorders, or as a concerned family member, friend or colleague, are most effective in communicating to legislators and their staff that there are real human beings behind the statistics. However, even general expressions of support are helpful.

HR 2311 is bipartisan legislation (supported by members of both parties) and according to IFFGD discussions with IBS Impact,  is “revenue-neutral,” meaning that there will be no additional taxes or spending added to the current federal deficit if it is enacted. Discretionary funds are available at the National Institutes of Health to be allocated if Congress directs NIH, through this Act, that functional gastrointestinal and motility disorders are a priority. Congress will only do so if we, as a community, are able to show them the importance of the research, education and FDA coordination provided for in HR 2311.

NIH grants funding to researchers throughout the world, not just in the U.S., so in the long run, enactment of this Act may also benefit readers with IBS in other countries. Medical research also sometimes involves multinational teams of scientists, and in any case, study results are usually published globally, adding to the cumulative knowledge worldwide.

It is IBS Impact’s understanding that HR 2311 will not require a debate or vote on the floor of the House of Representatives, and will pass as soon as it reaches 218 sponsor/cosponsors, or a simple majority of the House. In order for this milestone to be accomplished during the current Congress, the 114th,  the necessary number of sponsor/cosponsors must be reached by December 2016. Every two years, the Congressional membership will be different as a result of elections. Thus, if HR 2311 has not passed by that time,  a similar bill will have to be reintroduced and the FGIMD community will have to start the process of gathering co-sponsors anew. This is what occurred with HR 2239 in 2012 and HR 842 in 2014. While it is quite common for legislation of various sorts to take several Congresses to pass, our continuing advocacy now can increase awareness, build momentum and perhaps accelerate passage. It is in our hands.

Check back on this blog or join IBS Impact’s Facebook page or Twitter feed for further updates on HR 2311 as they occur. Links to the social media sites can be found on the right sidebar of the blog.


GERD Awareness Week: November 22-28, 2015

November 26, 2015

This week is the 17th annual GERD Awareness Week. Gastroesophageal reflux disease, like IBS, falls under the broad category of functional gastrointestinal and motility disorders, and many people with IBS also have GERD. According to About.com IBS Guide Barbara Bradley Bolen, PhD, some studies show that over 70% of people with IBS report some symptoms of GERD and vice versa, but that among those with actual diagnoses, the overlap rate ranges from about one-quarter to one-third. GERD occurs when the lower esophageal sphincter, the valve connecting the esophagus to the stomach, fails to close completely and consistently when needed, and stomach acids and digested food inappropriately back up into the esophagus on a recurring basis. GERD is estimated to affect at least 20% of American adults, both men and women. GERD also commonly affects children of all ages, including infants. A wide variety of lifestyle factors, medical conditions and medication side effects are thought to be possible factors in causing or exacerbating GERD.

Symptoms vary from person to person and are not restricted to heartburn. Some people may not have noticeable symptoms at all until they experience complications. Some other possible symptoms of GERD are: belching, coughing, hoarseness, difficulty or pain in swallowing, excessive saliva, the sensation of food sticking in the esophagus,  chronically sore or irritated throat, laryngitis, inflammation of the gums, erosion of tooth enamel, bitter taste in the mouth, and bad breath. Chest pain may also be a symptom of GERD, but should receive immediate medical attention to rule out the possibility of cardiac problems or other serious conditions. Other possible symptoms of GERD occurring more than once a week or the need to use non-prescription heartburn/reflux medications for more than two weeks without resolution should be discussed with a doctor.

Relative to other functional gastrointestinal and motility disorders, GERD is generally considered by physicians and many affected people to be quite treatable by a variety of lifestyle and diet modifications, prescription medications and/or surgery. Many people have mild GERD and, with appropriate medical care, are at low risk of serious complications, but untreated GERD can lead to inflammation, erosion or narrowing of the esophagus or in a small percentage of cases, Barrett’s esophagus, cell changes that heighten the risk of esophageal cancer. According to a brief extract of a longer IFFGD publication by Carlo DiLorenzo, M.D. of Children’s Hospital of Columbus and Ohio State University, Dr. Mark Glassman, MD of Sound Shore Medical Center in New Rochelle, New York, and Paul Hyman, M.D. of Children’s Hospital in New Orleans, Louisiana, some children with GERD and other conditions such as asthma, cystic fibrosis, abnormal lung development due to premature birth, muscle or nerve disorders affecting swallowing, or esophageal dysplasia, are at risk of GERD complicating those conditions.

Please see the following links for further information and resources and the original source for Drs. DiLorenzo, Glassman and Hyman’s work mentioned above.  IFFGD also offers downloadable GERD, IBS and functional GI disorder awareness brochures and posters for anyone to hang or distribute in his or her own community, that are accessible from the IFFGD links posted here. As today is American Thanksgiving, readers may find IFFGD’s holiday GERD-reducing tips to be particularly useful.

 GERD Awareness Week section from the IFFGD About GERD website

Pediatric GERD section from the IFFGD About Kids  GI website

Medline Plus page on GERD  (subunit of the U.S. National Institutes of Health)

In addition to encouraging accurate awareness of irritable bowel syndrome, IBS Impact encourages awareness of related conditions that are known to often overlap with IBS, as improvement in symptom management, treatment options, public awareness and social resources may have overlapping positive effects that improve quality of life for some people with IBS. With the high prevalence of GERD in the general public, many people who are not otherwise aware of or who do not take particular interest in functional gastrointestinal and motility disorders may actually have GERD or be close to someone who does. This is another opportunity to educate them about GERD and about FGIMDs in general as issues that do indeed involve them.


Follow

Get every new post delivered to your Inbox.

Join 855 other followers